Hemorrhagic Disorders

• Investigational Site Number 0140 — Little Rock, Arkansas, United States
• Investigational Site Number 128 — Gainesville, Florida, United States
• Investigational Site Number 103 — Tampa, Florida, United States
• Investigational Site Number 102 — Chicago, Illinois, United States

• Investigational Site Number 0117 — Phoenix, Arizona, United States
• Investigational Site Number 0139 — Los Angeles, California, United States
• Investigational Site Number 0135 — Orange, California, United States
• Investigational Site Number 0137 — San Diego, California, United States

• Indiana Hemophilia and Thrombosis Center — Indianapolis, Indiana, United States
• Louisiana Center for Bleeding & Clotting Disorders — New Orleans, Louisiana, United States
• National Institutes of Health - Warren G. Magnuson Clinical Center — Bethesda, Maryland, United States
• Tufts Medical Center — Boston, Massachusetts, United States

Not specified

• Hôpital d'Instruction des armées Percy - Laboratoire d'Hématologie — Clamart, France

• Hospital Universitario Ramón y Cajal — Madrid, Spain

• Arkansas Children's Hospital — Little Rock, Arkansas, United States
• Mattel Children's Hospital — Los Angeles, California, United States
• Children's Hospital of Oakland — Oakland, California, United States
• Children's Hospital of Orange County — Orange, California, United States

• Novartis Investigative Site — Camperdown, New South Wales, Australia
• Novartis Investigative Site — Woolloongabba, Queensland, Australia
• Novartis Investigative Site — Leuven, Belgium
• Novartis Investigative Site — Toronto, Ontario, Canada

• Hospital Unit West — Herning, Mid-Jutland, Denmark

• Office-based practitioner — Albens, France
• Office-based practitioner — Bordeaux, France
• Office-based practitioner — Chablis, France
• Office-based general practitioner — Dessenheim, France